Literature DB >> 6447071

Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridine.

W Bollag, H R Hartmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6447071     DOI： 10.1016/0014-2964(80)90221-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  33 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

2.  Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compounds.

Authors:  M Iigo; M Miwa; H Ishitsuka; K Nitta
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Pre-operative radiochemotherapy of locally advanced rectal cancer.

Authors:  Xiao-Nan Sun; Qi-Chu Yang; Jian-Bin Hu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

4.  Human urinary excretion of doxifluridine and metabolites during a 5-day chemotherapeutic schedule using fluorine-19 nuclear magnetic resonance spectrometry.

Authors:  M C Malet-Martino; P Servin; J Bernadou; J P Armand; R Martino
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

5.  The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.

Authors:  M Nishiyama; S Takagami; Y Kirihara; T Saeki; N Hirabayashi; Y Nosoh; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1988-11

6.  Impact of the new AJCC staging system and adjuvant treatment in rectal cancer.

Authors:  Shin Ae Lee; Hyuk-Chan Kwon; Min Ah Park; Chang Kil Jung; Sung-Hyun Kim; Ki-Jae Park; Hong-Jo Choi; Hyung-Sik Lee; Mee Sook Roh; Jae-Seok Kim; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2004-04-30       Impact factor: 4.679

7.  Capecitabine for locally advanced and metastatic colorectal cancer: A review.

Authors:  Georgios V Koukourakis; Georgios Zacharias; John Tsalafoutas; Dimitrios Theodoridis; Vassilios Kouloulias
Journal:  World J Gastrointest Oncol       Date:  2010-08-15

8.  Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.

Authors:  H Eda; K Fujimoto; S Watanabe; M Ura; A Hino; Y Tanaka; K Wada; H Ishitsuka
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  New approach to metabolism of 5'-deoxy-5-fluorouridine in humans with fluorine-19 NMR.

Authors:  M C Malet-Martino; R Martino; A Lopez; J P Béteille; M Bon; J Bernadou; J P Armand
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

10.  Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanoma.

Authors:  P Alberto; M Rozencweig; M Clavel; P Siegenthaler; F Cavalli; S Gundersen; U Bruntsch; J Renard; H Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.